603669 Lionco Pharmaceutical Group
- 6.08
- +0.04+0.66%
Lionco Pharmaceutical Group News
Lingkang Pharmaceutical: 2021 Annual Equity Distribution Implementation Notice
Lingkang Pharmaceutical: Announcement on the tracking rating results of “Lingkang Convertible Bonds” in 2022
Lingkang Pharmaceutical Group Co., Ltd. principal and “Lingkang Convertible Bonds” 2022 tracking rating report
Announcement on the tracking rating results of “Lingkang Convertible Bonds” in 2022
Lingkang Pharmaceutical: Convertible Corporate Bond Interest Payment Announcement
Lingkang Pharmaceutical: Announcement on the 2021 tracking rating results of “Lingkang Convertible Bonds”
Lingkang Pharmaceutical: Lingkang Pharmaceutical Group Co., Ltd. Entity and “Lingkang Convertible Bonds” 2021 Annual Tracking Rating Report
Lingkang Pharmaceutical: Credit Rating Report on Publicly Issued Convertible Corporate Bonds
Lingkang Pharmaceutical: Online Roadshow Announcement on the Public Issuance of Convertible Corporate Bonds
Lingkang Pharmaceutical: Response Report to the “Letter on Preparing for the Development and Review Committee Meeting on the Public Issuance of Convertible Corporate Bonds by Lingkang Pharmaceutical Group Co., Ltd.” (Revised Draft)
Lingkang Pharmaceutical: Response Report to Feedback on Application Documents for the Public Issuance of Convertible Corporate Bonds
Lingkang Pharmaceutical: Announcement on the acceptance of the application for the public issuance of A-share convertible corporate bonds by the China Securities Regulatory Commission
Lingkang Pharmaceutical: Feasibility Analysis Report on the Use of Funds Raised by Publicly Issuing Convertible Corporate Bonds
Lingkang Pharmaceutical: Plan to publicly issue A-share convertible corporate bonds
Lingkang Pharmaceutical: Notice on Diluted Immediate Returns and Compensation Measures for the Public Issuance of Convertible Corporate Bonds
Lingkang Pharmaceutical: Supplemental Announcement on Acquisition of Shares in Hainan Cancer Hospital Chengmei International Medical Center Co., Ltd.
Lingkang Pharmaceutical: Announcement on the acquisition of shares in Hainan Cancer Hospital Chengmei International Medical Center Co., Ltd.
Lingkang Pharmaceutical: Appendix to the Prospectus for the Initial Public Offering of Shares
Analysis
Price Target
No Data
No Data